| 产品详情 |
| Edit |   |
|---|
| Product Name | Human CellExp CD80, Human Recombinant |
|---|
| Description | This protein is fused with 6xHis tag at the C-terminus, has a calculated MW of 24.7 kDa. The predicted N-terminus is Val 35. DTT-reduced Protein migrates as 45-75 kDa due to different glycosylation. Purity ≥95%. Background: B7-1 and B7-2, together with their receptors CD28 and CTLA-4, constitute one of the dominant co-stimulatory pathways that regulate T- and B-cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20 - 100 fold higher |
|---|
| Size | 0.01 mg, 0.05 mg |
|---|
| Concentration | n/a |
|---|
| Applications | SDS-PAGE |
|---|
| Other Names | [CD80; B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7] |
|---|
| Gene, Accession, CAS # | CD80, Gene ID: 941, Accession: NP_005182.1 |
|---|
| Catalog # | MBS845337 |
|---|
| Price | |
|---|
| Order / More Info | Human CellExp CD80, Human Recombinant from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|